April McVey

3.0k total citations
35 papers, 939 citations indexed

About

April McVey is a scholar working on Neurology, Genetics and Epidemiology. According to data from OpenAlex, April McVey has authored 35 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 7 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in April McVey's work include Amyotrophic Lateral Sclerosis Research (11 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Myasthenia Gravis and Thymoma (6 papers). April McVey is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (11 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Myasthenia Gravis and Thymoma (6 papers). April McVey collaborates with scholars based in United States, United Kingdom and Saudi Arabia. April McVey's co-authors include Richard J. Barohn, Mazen M. Dimachkie, Laura Herbelin, Carlayne E. Jackson, Richard J. Barohn, Mamatha Pasnoor, Gary Gronseth, J. Mendell, Jeffrey Statland and Susan Rogers and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Journal of the Neurological Sciences.

In The Last Decade

April McVey

33 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
April McVey United States 16 492 194 180 173 172 35 939
Keith Pohl United Kingdom 17 219 0.4× 158 0.8× 196 1.1× 126 0.7× 106 0.6× 31 762
Tomihiro Imai Japan 18 717 1.5× 70 0.4× 147 0.8× 53 0.3× 63 0.4× 87 1.2k
Valentina Citton Italy 13 192 0.4× 143 0.7× 98 0.5× 38 0.2× 68 0.4× 34 718
Thomas Julian United Kingdom 12 241 0.5× 90 0.5× 97 0.5× 59 0.3× 180 1.0× 25 643
Zaeem A. Siddiqi Canada 18 629 1.3× 78 0.4× 134 0.7× 30 0.2× 126 0.7× 61 1.1k
Aisling Ryan Ireland 13 211 0.4× 82 0.4× 197 1.1× 30 0.2× 101 0.6× 34 671
Panagiotis Kokotis Greece 16 389 0.8× 64 0.3× 71 0.4× 37 0.2× 200 1.2× 66 753
Robert S. Hepler United States 24 441 0.9× 240 1.2× 106 0.6× 52 0.3× 49 0.3× 56 1.5k
Stephen Boone United States 12 777 1.6× 162 0.8× 116 0.6× 25 0.1× 82 0.5× 30 1.2k
Servet İnci Türkiye 17 437 0.9× 115 0.6× 90 0.5× 25 0.1× 38 0.2× 48 797

Countries citing papers authored by April McVey

Since Specialization
Citations

This map shows the geographic impact of April McVey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April McVey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April McVey more than expected).

Fields of papers citing papers by April McVey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April McVey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April McVey. The network helps show where April McVey may publish in the future.

Co-authorship network of co-authors of April McVey

This figure shows the co-authorship network connecting the top 25 collaborators of April McVey. A scholar is included among the top collaborators of April McVey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April McVey. April McVey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Innes, John, B. Duncan X. Lascelles, Daniel Bell, et al.. (2025). A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis. Frontiers in Veterinary Science. 12. 1502218–1502218. 2 indexed citations
2.
McVey, April, Richard J. Barohn, Jeffrey Statland, et al.. (2020). Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets. Journal of Visualized Experiments. 1 indexed citations
3.
McVey, April, Richard J. Barohn, Jeffrey Statland, et al.. (2020). Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets. Journal of Visualized Experiments. 4 indexed citations
4.
Dimachkie, Mazen M., Vera Bril, Todd Levine, et al.. (2019). Subcutaneous Immunoglobulin in Myasthenia Gravis: Results of a North American Open Label Study (N4.002). Neurology. 92(15_supplement). 5 indexed citations
5.
Fournier, Christina, Hiroshi Mitsumoto, Catherine Lomen‐Hoerth, et al.. (2016). Primary Lateral Sclerosis and Early Upper Motor Neuron Disease. Journal of Clinical Neuromuscular Disease. 17(3). 99–105. 17 indexed citations
6.
Jabari, Duaa, Mazen M. Dimachkie, Jeffrey Statland, et al.. (2015). Stiff Person Syndrome: A case series (P7.053). Neurology. 84(14_supplement).
7.
Johnson, Nicholas E., W. David Arnold, Kelly Gwathmey, et al.. (2015). Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patients. Neuromuscular Disorders. 25(8). 625–631. 13 indexed citations
8.
Statland, Jeffrey, Richard J. Barohn, April McVey, Jonathan Katz, & Mazen M. Dimachkie. (2015). Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. Neurologic Clinics. 33(4). 735–748. 69 indexed citations
9.
Dimachkie, Mazen M., Mamatha Pasnoor, Richard J. Barohn, et al.. (2015). Utility of Screening for Monoclonal Gammopathy in ALS (P4.128). Neurology. 84(14_supplement).
10.
Dimachkie, Mazen M., Jonathan Katz, Carlayne E. Jackson, et al.. (2013). Leg Amyotrophic Diplegia. Journal of Clinical Neuromuscular Disease. 15(1). 7–12. 8 indexed citations
11.
Anderson, Neil E., et al.. (2012). Facial Onset Sensorimotor Neuronopathy Syndrome. Journal of Clinical Neuromuscular Disease. 14(1). 7–10. 13 indexed citations
12.
Mittal, Manoj, Richard J. Barohn, Mamatha Pasnoor, et al.. (2011). Ocular Myasthenia Gravis in an Academic Neuro-Ophthalmology Clinic: Clinical Features and Therapeutic Response. Journal of Clinical Neuromuscular Disease. 13(1). 46–52. 43 indexed citations
13.
Mittal, Manoj, Mamatha Pasnoor, April McVey, et al.. (2011). Retrospective Chart Review of Duloxetine and Pregabalin in the Treatment of Painful Neuropathy. International Journal of Neuroscience. 121(9). 521–527. 14 indexed citations
14.
Jackson, Carlayne E., Gary Gronseth, Jeffrey Rosenfeld, et al.. (2009). Randomized double‐blind study of botulinum toxin type B for sialorrhea in als patients. Muscle & Nerve. 39(2). 137–143. 107 indexed citations
15.
Barohn, Richard J., Laura Herbelin, J. T. Kissel, et al.. (2006). Pilot trial of etanercept in the treatment of inclusion-body myositis. Neurology. 66(1_suppl_1). S123–4. 80 indexed citations
16.
Grogan, Pauline, Scott Tanner, K.H. Örstavik, et al.. (2005). Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations. Neurology. 64(9). 1638–1640. 21 indexed citations
17.
Wolfe, Gil I., et al.. (2005). Brachial plexopathy following thoracoscapular fusion in facioscapulohumeral muscular dystrophy. Neurology. 64(3). 572–573. 6 indexed citations
18.
Amato, Anthony A., et al.. (1997). Evaluation of Neuromuscular Symptoms in Veterans of the Persian Gulf War. Neurology. 48(1). 4–12. 78 indexed citations
19.
Barohn, Richard J., et al.. (1994). Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle & Nerve. 17(6). 647–654. 75 indexed citations
20.
Barohn, Richard J., et al.. (1993). Peripheral Nervous System Involvement in a Large Cohort of Human Immunodeficiency Virus--Infected Individuals. Archives of Neurology. 50(2). 167–171. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Pohl Breakdown of academic impact, for papers by Tomihiro Imai Breakdown of academic impact, for papers by Valentina Citton Breakdown of academic impact, for papers by Thomas Julian Breakdown of academic impact, for papers by Zaeem A. Siddiqi Breakdown of academic impact, for papers by Aisling Ryan Breakdown of academic impact, for papers by Panagiotis Kokotis Breakdown of academic impact, for papers by Robert S. Hepler Breakdown of academic impact, for papers by Stephen Boone Breakdown of academic impact, for papers by Servet İnci
Rankless by CCL
2026